Recon: Pfizer to sell its stake in GSK consumer business after London listing; Sage postpartum depression drug hits goals in Phase III
Recon
BiologicsBiotechnologyDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy